Results 211 to 220 of about 32,100 (296)

Comparative Cardiovascular Safety and Exploratory Bleeding Outcomes of Ibrutinib, Acalabrutinib, and Zanubrutinib in Mantle Cell Lymphoma: A Propensity Score‐Matched Real‐World Analysis

Cancer Medicine, Volume 15, Issue 8, August 2026.
ABSTRACT Background Bruton tyrosine kinase inhibitors are central to the treatment of relapsed or refractory mantle cell lymphoma, but cardiovascular and bleeding toxicities influence treatment selection. Ibrutinib has been associated with atrial fibrillation/flutter and other cardiovascular adverse events, whereas second‐generation covalent BTK ...
Anna Homeniuk, Amrit Sandhu, Leena Abdalla, Anas Atrash   +3 more
wiley   +1 more source

Cardiotoxicity of monoclonal antibody-based therapies in breast cancer: a contemporary narrative review. [PDF]

Cardiooncology
Santos Nussbaum ACA, Antonini M, Mattar A, Bacal F, Monte Real J.   +4 more
europepmc   +1 more source

Early Risk Identification of Sepsis During Induction Chemotherapy in Newly Diagnosed AML: A Nomogram‐Based Tool

Cancer Medicine, Volume 15, Issue 8, August 2026.
ABSTRACT Background Patients with acute myeloid leukemia (AML) experience severe infections frequently during and after chemotherapy. The purpose of this study was to develop an early risk assessment tool to identify newly diagnosed AML patients at high risk of developing sepsis during the early phase of induction chemotherapy.
Cui‐Ying Gu, Ya‐Shu Feng, Qing‐Song He, Ling Zhang, Jia‐Jun Liu   +4 more
wiley   +1 more source

The CHECK HEART Score: A Practical Tool for Cardiotoxicity Risk Stratification. [PDF]

JACC Asia
Govind A.
europepmc   +1 more source

Therapeutic Efficacy of Metronomic Doxorubicin and Low Dose of Gamma Radiation on Breast Cancer Model

Cell Biochemistry and Function, Volume 44, Issue 8, August 2026.
ABSTRACT Breast cancer is the most common malignancy in females internationally. Doxorubicin (DOX) has been well‐thought‐out as the most effective regimen for breast cancer treatment for several years. The chronic side effects of DOX obligate us to control the dosage that can be used, although its efficacy.
Ibrahim Y. Abdelrahman, Mostafa Saif‐Elnasr, Zeinab R. Attia, Rania A. Abd El Azeem, Eman Khalifa, Mostafa A. Askar   +5 more
wiley   +1 more source

Total body irradiation and smoking interact to increase lung cancer risk after blood or marrow transplantation. [PDF]

Blood Adv
Balas N, Chen Y, Meng Q, Hageman L, Landier W, Richman J, Bosworth A, Wong FL, Bhatia R, Weisdorf DJ, Armenian SH, Bhatia S.   +11 more
europepmc   +1 more source

Acute Myeloid Leukemia in a Patient With Xeroderma Pigmentosum: A Case Report

Clinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT Acute myeloid leukemia may occur in patients with xeroderma pigmentosum at a younger age and can be associated with complex cytogenetics and poor treatment response, highlighting the importance of regular hematologic monitoring.
Mina Soryal, Mohamed Mahmoud Marey, Malak A. Hassan, Rawan El‐Sayed, Enas Kamal Abdalaziz Seyed, Ashraf Elghandour   +5 more
wiley   +1 more source

Transcriptomic biomarkers related to cardiac disease in childhood cancer survivors: a case-control study. [PDF]

Eur Heart J
Aba N, Le Teuff G, Fresneau B, Koscielny S, Belhechmi S, Schwartz B, El-Fayech C, Rubino C, Allodji RS, Morel E, Dayde D, de la Grange P, Jolly A, Pata-Merci N, Cordero C, Aerts I, Pein F, Vu-Bezin G, De Vathaire F, Haddy N.   +19 more
europepmc   +1 more source

Primary Cervical Angiosarcoma Presenting With Transfusion‐Dependent Bleeding in Early Pregnancy: Diagnostic and Management Challenges

Clinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT Persistent vaginal bleeding during pregnancy should not be attributed solely to obstetric causes. Rare cervical malignancies, including angiosarcoma, may present with life‐threatening anemia, and MRI with early biopsy is essential to avoid diagnostic delay.
Ammir Abuzahra, Ruba Atawneh, Siwar Abu Sakout, Raya Abu Ayyash, Jana Dwaik   +4 more
wiley   +1 more source

Sarcoma: Cardiovascular and Oncologic Considerations: JACC: CardioOncology State-of-the-Art Review. [PDF]

JACC CardioOncol
Lefler DS, Nassif Haddad EF, Nohria A, Agulnik M, Crane J, Fradley MG.   +5 more
europepmc   +1 more source